
P115 (0048) BRENTUXIMAB VEDOTIN (BV) AS MAINTENANCE OR SALVAGE THERAPY AFTER ASCT FOR RELAPSED/REFRACTORY (R/R) HL
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547960.36500.e8
Subject(s) - brentuximab vedotin , oncology , refractory (planetary science) , medicine , salvage therapy , chemotherapy , hodgkin lymphoma , materials science , lymphoma , metallurgy